Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HNL Genomics is the specialized genetic testing division of HNL Lab Medicine, a leading multi-regional clinical laboratory based in Allentown, Pennsylvania. The division provides a comprehensive suite of genomic services across three primary areas: Inherited Genetics, Molecular Oncology, and Cytogenetics. Utilizing advanced technologies such as Next-Generation Sequencing (NGS), chromosome microarray, and fluorescence in situ hybridization (FISH), HNL Genomics offers over 3,300 unique tests covering more than 1,000 genes. The company serves healthcare providers by delivering actionable insights for personalized treatment plans in oncology, cardiology, and prenatal care, emphasizing industry-leading turnaround times and high-quality diagnostic accuracy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HNL Genomics.